An E7-based therapeutic vaccine protects mice against HPV16 associated cancer
β Scribed by Aldo Venuti; Silvia Massa; Vadim Mett; Laura Dalla Vedova; Francesca Paolini; Rosella Franconi; Vidadi Yusibov
- Book ID
- 116961308
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 169 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0264-410X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The cellular tumor suppressor p16 is strongly overexpressed in cervical cancers and precancers. We have previously demonstrated that infiltrating T lymphocytes reactive against p16 can be found in cervical cancer patients. Here, we analyzed whether p16 induces humoral immune responses.
HPV L1-based virus-like particles vaccines (VLPs) efficiently induce temporary prophylactic activity through the induction of neutralizing antibodies; however, VLPs that can provide prophylactic as well as therapeutic properties for longer periods of time are needed. For this purpose, we generated a